Results 151 to 160 of about 7,033,015 (228)

Cholesteryl ester transfer protein inhibition with obicetrapib is associated with attenuated decline in kidney function in patients at high cardiovascular risk: Post hoc pooled results from the BROADWAY and BROOKLYN trials. [PDF]

Am J Prev Cardiol
Vogt L, Davidson MH, Szarek M, Kling D, Dicklin MR, Curcio D, Ditmarsch M, Hsieh A, Wicks DL, Ortiz N, Kastelein JJP.   +10 more
europepmc   +1 more source

Cholesteryl Ester Transfer Protein Impairs Triglyceride Clearance via Androgen Receptor in Male Mice. [PDF]

Lipids, 2021
Palmisano BT, Anozie U, Yu S, Neuman JC, Zhu L, Edington EM, Luu T, Stafford JM.   +7 more
europepmc   +1 more source

Comparative Effectiveness of Cholesteryl Ester Transfer Protein (CETP) Inhibitors on Lipid Profiles in Adults With Hyperlipidemia: A Comprehensive Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials. [PDF]

Clin Cardiol
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Abrar S, Jamil TB, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter M.   +15 more
europepmc   +1 more source

Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity. [PDF]

Curr Opin Lipidol
Davidson MH, Hsieh A, Kastelein JJP.
europepmc   +1 more source

Human cholesteryl ester transfer protein lacks lipopolysaccharide transfer activity, but worsens inflammation and sepsis outcomes in mice. [PDF]

J Lipid Res, 2021
Dusuel A, Deckert V, Pais de Barros JP, van Dongen K, Choubley H, Charron É, Le Guern N, Labbé J, Mandard S, Grober J, Lagrost L, Gautier T.   +11 more
europepmc   +1 more source

Cholesteryl ester transfer protein inhibition

Current opinion in lipidology
PURPOSE OF REVIEW: To review the evidence and describe the biological plausibility for the benefits of inhibiting cholesteryl ester transfer protein (CETP) on multiple organ systems through modification of lipoprotein metabolism. RECENT FINDINGS: Results from observational studies, Mendelian randomization analyses, and randomized clinical trials ...
Davidson, Michael H., Hsieh, Andrew, Kastelein, John J. P.   +2 more
openaire   +1 more source

Correction: Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a mendelian randomization analysis. [PDF]

Alzheimers Res Ther
Schmidt AF, Davidson MH, Ditmarsch M, Kastelein JJ, Finan C.   +4 more
europepmc   +1 more source

The impact of cholesteryl ester transfer protein on the progression of cutaneous leishmaniasis. [PDF]

Front Immunol
Batista-Dantas FE, Ozaki CY, Santana KG, Nunes VS, Uscata BA, Siess-Portugal C, Reis LC, Yamashiro-Kanashiro EH, Tafuri WL, Duarte-Neto AN, Sotto MN, Goto H, Cazita PM.   +12 more
europepmc   +1 more source

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis. [PDF]

Alzheimers Res Ther
Schmidt AF, Davidson MH, Ditmarsch M, Kastelein JJ, Finan C.   +4 more
europepmc   +1 more source

Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease. [PDF]

Arterioscler Thromb Vasc Biol, 2022
Furtado JD, Ruotolo G, Nicholls SJ, Dullea R, Carvajal-Gonzalez S, Sacks FM.   +5 more
europepmc   +1 more source